The FDA first announced the detection of high levels of NDMA, a contaminant associated with cancer, in extended-release metformin products back in May 2020. 

The study's authors noted that patients should keep taking their medications as normal. However, they see a definite need for more research in this area.

The study included more than 400 patients with a history of mild or moderate COVID-19. 

Significant issues have been reported with the catheter’s guidewire.

Many healthcare groups remain concerned about the law's potential long-term impact on providers and patients alike. 

Abusing these supplements, a practice often seen in athletics, can lead to significant health issues. 

A total of 40 different diets were included in the evaluation.

Researchers detailed the case in Circulation: Cardiovascular Imaging.

The device's filter is breaking off during the retrieval process, making it much more difficult to withdraw. 

The new analysis, published in the New England Journal of Medicine, represents the latest chapter in one of interventional cardiology’s largest ongoing debates.